Small Animal Imaging In Vivo Market Growth & Forecast [2031]

Segments - Small Animal Imaging In-vivo Market by Technology (Nuclear Imaging, Optical Imaging, Micro-magnetic Resonance Imaging, and Other Imaging Modalities [Micro-ultrasound and Micro-CT]), Applications (Cancer Cell Detection, Monitoring Treatment Response, Biomarkers, Bio-distribution, Epigenetics, and Longitudinal Studies), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Small Animal Imaging In-vivo Market Outlook 2031:

The global small animal imaging in-vivo market size was valued at USD 2.50 Billion in 2022 and is projected to reach USD 5.47 Billion by 2031, expanding at a CAGR of 9.1% during the forecast period 2023 - 2031.

The growth of the market is attributed to the growing application of in-vivo imaging and the increasing number of research organizations. In-vivo imaging has high-resolution modalities and provides data storage in real-time that are other factors fueling the further market expansion.

The in-vivo imaging system includes a range of instruments that are not introduced or invaded in the body while using for diagnostic or research purposes. These devices are used for various applications including evaluation of new molecules for bio-distribution patterns, monitoring the response given by drugs during the development of new drugs, and research for the cancer cell.

Small Animal Imaging In-vivo Market Outlook

Small animal imaging in-vivo has different modalities that are achieving remarkable consequences regards to receptor targeting, providing the definition of action mechanism, and research studies related to epigenetic. The use and development of multimodal instruments is expected to exhibit rapid growth both in preclinical and clinical phases due to ongoing technological evolution.

Various imaging can be performed using non-invasive modalities that include molecular, structural, and functional imaging. The introduction of rarefaction technology along with the development of novel instruments are anticipated to drive the overall market expansion due to the increasing usage of molecular imaging in biology & medicine.

The primary objective of molecular imaging using non-invasive methods is to quantify, visualize, and characterize the pathological & normal biological activities at sub-cellular or cellular levels that occur in the living organisms.

Small Animal Imaging In-vivo Market Trends, Drivers, Restraints, and Opportunities

Growing demand for in-vivo imaging techniques and their applications in various domains is anticipated to fuel the market growth during the forecast period.
Technological innovations along with the technological advancements in molecular imaging research are expected to propel the market growth in the coming years.
Existing strict regulatory frameworks coupled with the presence of complex reimbursement policies across countries are major challenges that can restrain the market expansion.
Increasing number of healthcare initiatives by both public & private sector in order to support researches are estimated to fuel the market growth over the forecast period.
Ongoing research & development and wide investments from key pharmaceutical companies are projected to create lucrative opportunities for the market expansion.

Scope of the Small Animal Imaging In-vivo Market Report

The report on the global small animal imaging in-vivo market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Small Animal Imaging In-vivo Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Technology (Nuclear Imaging, Optical Imaging, Micro-magnetic Resonance Imaging, and Other Imaging Modalities [Micro-ultrasound and Micro-CT]) and Applications (Cancer Cell Detection, Monitoring Treatment Response, Biomarkers, Bio-distribution, Epigenetics, and Longitudinal Studies)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Aspect Imaging Ltd.; Miltenyi Biotec GmbH; FujiFilm Holding Corp.; Life Technologies Corp.; Siemens AG; Thermo Fisher Scientific; PerkinElmer Inc.; Bruker Corp.; and Promega Corp., Inc.

Small Animal Imaging In-vivo Market Segment Insights

Micro-magnetic resonance imaging segment is anticipated to expand at a high CAGR

On the basis of technology, the global small animal imaging in-vivo market is divided into nuclear imaging, optical imaging, micro-magnetic resonance imaging, and other imaging modalities. The other imaging modalities segment is further bifurcated into micro-ultrasound and micro-CT.

The optical imaging segment held a major share of the market in 2019 and is expected to account for a key market share in the coming years owing to its cost-effectiveness along with easy & rapid operations as compared to other modalities.

However, the micro-magnetic resonance imaging segment is anticipated to expand at a high CAGR attributed to its specific & precise operations that provide better results in the preclinical research phase.

Small Animal Imaging In-vivo Market Technology

Cancer cell detection segment is estimated to grow at a rapid pace

Based on applications, the market is segmented into cancer cell detection, monitoring treatment response, biomarkers, bio-distribution, epigenetics, and longitudinal studies.

The bio-distribution segment held a key share of the market in 2019 and is expected to continue its dominance of the market in the coming years. However, cancer cell detection segment is estimated to grow at a rapid pace owing to the increasing incidence of cancer cases across the globe.

Small Animal Imaging In-vivo Market Applications

North America is anticipated to dominate the market

In terms of regions, the global small animal imaging in-vivo market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major share of the market in 2019 and is anticipated to dominate the market during the forecast period attributed to technological advancements and innovations made for innovative modalities.

Various numbers of preclinical researches in the region is also expected to fuel the market expansion. North America is followed by Europe as the second large market attributed to the presence of pharmaceutical organizations, clinical research, and a huge number of manufacturers of diagnostic devices in the latter region. On the other hand, the market of Asia Pacific is also estimated to grow at a rapid pace during the forecast period due to changes in clinical research activities.

Small Animal Imaging In-vivo Market Region

Segments

The global small animal imaging in-vivo market has been segmented on the basis of

Technology

Nuclear Imaging
Optical Imaging
Micro-magnetic Resonance Imaging
Other Imaging Modalities
- Micro-ultrasound
- Micro-CT

Applications

Cancer Cell Detection
Monitoring Treatment Response
Biomakers
Bio-distribution
Epigebetics
Longitudinal Studies

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Aspect Imaging Ltd.
Miltenyi Biotec GmbH
FujiFilm Holding Corp.
Life Technologies Corp.
Siemens AG
Thermo Fisher Scientific
PerkinElmer Inc.
Bruker Corp.
Promega Corp., Inc.

Competitive Landscape

Key players competing in the global small animal imaging in-vivo market are Aspect Imaging Ltd.; Miltenyi Biotec GmbH; FujiFilm Holding Corp.; Life Technologies Corp.; Siemens AG; Thermo Fisher Scientific; PerkinElmer Inc.; Bruker Corp.; and Promega Corp., Inc.

Many of these players have adopted business strategies such as launching new products, advancement of technology, partnerships, mergers, and production capacity expansion in order to increase their expansion, their consumer base, and market position globally.

Small Animal Imaging In-vivo Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Small Animal Imaging In-vivo Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Small Animal Imaging In-vivo Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Small Animal Imaging In-vivo Market - Supply Chain
  4.5. Global Small Animal Imaging In-vivo Market Forecast
     4.5.1. Small Animal Imaging In-vivo Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Small Animal Imaging In-vivo Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Small Animal Imaging In-vivo Market Absolute $ Opportunity
5. Global Small Animal Imaging In-vivo Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     5.3.1. Cancer Cell Detection
     5.3.2. Monitoring Treatment Response
     5.3.3. Biomakers
     5.3.4. Bio-distribution
     5.3.5. Epigebetics
     5.3.6. Longitudinal Studies
     5.3.7.
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Small Animal Imaging In-vivo Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Small Animal Imaging In-vivo Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
7. North America Small Animal Imaging In-vivo Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Small Animal Imaging In-vivo Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     7.4.1. Cancer Cell Detection
     7.4.2. Monitoring Treatment Response
     7.4.3. Biomakers
     7.4.4. Bio-distribution
     7.4.5. Epigebetics
     7.4.6. Longitudinal Studies
     7.4.7.
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
8. Latin America Small Animal Imaging In-vivo Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Small Animal Imaging In-vivo Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     8.4.1. Cancer Cell Detection
     8.4.2. Monitoring Treatment Response
     8.4.3. Biomakers
     8.4.4. Bio-distribution
     8.4.5. Epigebetics
     8.4.6. Longitudinal Studies
     8.4.7.
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
9. Europe Small Animal Imaging In-vivo Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Small Animal Imaging In-vivo Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     9.4.1. Cancer Cell Detection
     9.4.2. Monitoring Treatment Response
     9.4.3. Biomakers
     9.4.4. Bio-distribution
     9.4.5. Epigebetics
     9.4.6. Longitudinal Studies
     9.4.7.
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
10. Asia Pacific Small Animal Imaging In-vivo Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Small Animal Imaging In-vivo Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     10.4.1. Cancer Cell Detection
     10.4.2. Monitoring Treatment Response
     10.4.3. Biomakers
     10.4.4. Bio-distribution
     10.4.5. Epigebetics
     10.4.6. Longitudinal Studies
     10.4.7.
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
11. Middle East & Africa Small Animal Imaging In-vivo Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Small Animal Imaging In-vivo Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Small Animal Imaging In-vivo Market Size and Volume Forecast by Applications
     11.4.1. Cancer Cell Detection
     11.4.2. Monitoring Treatment Response
     11.4.3. Biomakers
     11.4.4. Bio-distribution
     11.4.5. Epigebetics
     11.4.6. Longitudinal Studies
     11.4.7.
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Small Animal Imaging In-vivo Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Small Animal Imaging In-vivo Market: Market Share Analysis
  12.2. Small Animal Imaging In-vivo Distributors and Customers
  12.3. Small Animal Imaging In-vivo Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Aspect Imaging Ltd.
     12.4.2. Miltenyi Biotec GmbH
     12.4.3. FujiFilm Holding Corp.
     12.4.4. Life Technologies Corp.
     12.4.5. Siemens AG
     12.4.6. Thermo Fisher Scientific
     12.4.7. PerkinElmer Inc.